Murine vaginal colonization model for investigating asymptomatic mucosal carriage of streptococcus pyogenes

Infection and Immunity

Volumn 81, Issue 5, 2013, Pages 1606-1617

  Watson, Michael E ^a   Nielsen, Hailyn V ^a   Hultgren, Scott J ^a   Caparon, Michael G ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATABOLITE CONTROL PROTEIN A; ESTRADIOL; HYDROGEN PEROXIDE; LACTATE 2 MONOOXYGENASE;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BASEMENT MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE CONTROL; GENE EXPRESSION; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY CELL; LETHARGY; LEUKOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PYOGENES; ULCER; VAGINA DISCHARGE; VAGINA EPITHELIUM; VAGINA FLORA; VAGINA MUCOSA; WEIGHT REDUCTION;

EID: 84877817441     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00021-13     Document Type: Article

References (77)

1. Cunningham MW. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13:470 -511.
2. Cole JN, Barnett TC, Nizet V, Walker MJ. 2011. Molecular insight into invasive group A streptococcal disease. Nat. Rev. Microbiol. 9:724 -736.
3. Mead PB, Winn WC. 2000. Vaginal-rectal colonization with group A streptococci in late pregnancy. Infect. Dis. Obstet. Gynecol. 8:217-219.
4. McKee WM, Di Caprio JM, Roberts CE, Jr, Sherris JC. 1966. Anal carriage as the probable source of a streptococcal epidemic. Lancet ii: 1007-1009.
5. Stamm WE, Feeley JC, Facklam RR. 1978. Wound infections due to group A streptococcus traced to a vaginal carrier. J. Infect. Dis. 138:287- 292.
6. Berkelman RL, Martin D, Graham DR, Mowry J, Freisem R, Weber JA, Ho JL, Allen JR. 1982. Streptococcal wound infections caused by a vaginal carrier. JAMA 247:2680 -2682.
7. Stromberg A, Schwan A, Cars O. 1988. Throat carrier rates of betahemolytic streptococci among healthy adults and children. Scand. J. Infect. Dis. 20:411- 417.
8. Tanz RR, Shulman ST. 2007. Chronic pharyngeal carriage of group A streptococci. Pediatr. Infect. Dis. J. 26:175-176.
9. Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, Martin JM, Van Beneden C. 2012. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 55:e66-e102. doi:10.1093/cid/cis629.
10. Roberts S, Scott JR, Husmann LK, Zurawski CA. 2006. Murine models of Streptococcus pyogenes infection. Curr. Protoc. Microbiol. Chapter 9:Unit 9D.5. doi:10.1002/9780471729259.mc09d05s02.
11. Virtaneva K, Graham MR, Porcella SF, Hoe NP, Su H, Graviss EA, Gardner TJ, Allison JE, Lemon WJ, Bailey JR, Parnell MJ, Musser JM. 2003. Group A streptococcus gene expression in humans and cynomolgus macaques with acute pharyngitis. Infect. Immun. 71:2199 -2207.
12. Fidel PL, Jr, Lynch ME, Sobel JD. 1993. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis. Infect. Immun. 61:1990 -1995.
13. Meysick KC, Garber GE. 1992. Interactions between Trichomonas vaginalis and vaginal flora in a mouse model. J. Parasitol. 78:157-160.
14. Cheng Q, Nelson D, Zhu S, Fischetti VA. 2005. Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme. Antimicrob. Agents Chemother. 49:111-117.
15. Jerse AE. 1999. Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice. Infect. Immun. 67:5699- 5708.
16. Galand P, Leroy F, Chretien J. 1971. Effect of oestradiol on cell proliferation and histological changes in the uterus and vagina of mice. J. Endocrinol. 49:243-252.
17. Brenner RM, West NB. 1975. Hormonal regulation of the reproductive tract in female mammals. Annu. Rev. Physiol. 37:273-302.
18. Tripathi G. 1984. Antagonistic effects of estradiol dipropionate and progesterone on the histology of the vagina and uterus of the mouse. J. Exp. Zool. 232:151-155.
19. Exley RM, Wu H, Shaw J, Schneider MC, Smith H, Jerse AE, Tang CM. 2007. Lactate acquisition promotes successful colonization of the murine genital tract by Neisseria gonorrhoeae. Infect. Immun. 75:1318 -1324.
20. Jaquiery A, Stylianopoulos A, Hogg G, Grover S. 1999. Vulvovaginitis: clinical features, aetiology, and microbiology of the genital tract. Arch. Dis. Child. 81:64-67.
21. Anteby EY, Yagel S, Hanoch J, Shapiro M, Moses AE. 1999. Puerperal and intrapartum group A streptococcal infection. Infect. Dis. Obstet. Gynecol. 7:276 -282.
22. Meltzer MC, Schwebke JR. 2008. Lactational amenorrhea as a risk factor for group A streptococcal vaginitis. Clin. Infect. Dis. 46:e112- e115. doi: 10.1086/587748.
23. Rahangdale L, Lacy J, Hillard PA. 2008. Group A Streptococcus vulvovaginitis in breastfeeding women. Am. J. Obstet. Gynecol. 199:e4-e5. doi: 10.1016/j.ajog.2008.02.045.
24. Stricker T, Navratil F, Sennhauser FH. 2003. Vulvovaginitis in prepubertal girls. Arch. Dis. Child. 88:324 -326.
25. Eriksson BK, Norgren M, McGregor K, Spratt BG, Normark BH. 2003. Group A streptococcal infections in Sweden: a comparative study of invasive and noninvasive infections and analysis of dominant T28 emm28 isolates. Clin. Infect. Dis. 37:1189 -1193.
26. Colman G, Tanna A, Efstratiou A, Gaworzewska ET. 1993. The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease. J. Med. Microbiol. 39:165-178.
27. Chuang I, Van Beneden C, Beall B, Schuchat A. 2002. Population-based surveillance for postpartum invasive group A streptococcus infections, 1995-2000. Clin. Infect. Dis. 35:665- 670.
28. Green NM, Zhang S, Porcella SF, Nagiec MJ, Barbian KD, Beres SB, LeFebvre RB, Musser JM. 2005. Genome sequence of a serotype M28 strain of group A streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity. J. Infect. Dis. 192:760 -770.
29. Zhang S, Green NM, Sitkiewicz I, Lefebvre RB, Musser JM. 2006. Identification and characterization of an antigen I/II family protein produced by group A streptococcus. Infect. Immun. 74:4200-4213.
30. Cases I, de Lorenzo V. 2005. Promoters in the environment: transcriptional regulation in its natural context. Nat. Rev. Microbiol. 3:105-118.
31. Seshasayee AS, Bertone P, Fraser GM, Luscombe NM. 2006. Transcriptional regulatory networks in bacteria: from input signals to output responses. Curr. Opin. Microbiol. 9:511-519.
32. Shelburne SA, III, Keith D, Horstmann N, Sumby P, Davenport MT, Graviss EA, Brennan RG, Musser JM. 2008. A direct link between carbohydrate utilization and virulence in the major human pathogen groupA Streptococcus. Proc. Natl. Acad. Sci. U. S. A. 105:1698 -1703.
33. Kietzman CC, Caparon MG. 2010. CcpA and LacD.1 affect temporal regulation of Streptococcus pyogenes virulence genes. Infect. Immun. 78: 241-252.
34. Kietzman CC, Caparon MG. 2011. Distinct time-resolved roles for two catabolite-sensing pathways during Streptococcus pyogenes infection. Infect. Immun. 79:812- 821.
35. Warner JB, Lolkema JS. 2003. CcpA-dependent carbon catabolite repression in bacteria. Microbiol. Mol. Biol. Rev. 67:475- 490.
36. Deutscher J, Kuster E, Bergstedt U, Charrier V, Hillen W. 1995. Protein kinase-dependent HPr/CcpA interaction links glycolytic activity to carbon catabolite repression in gram-positive bacteria. Mol. Microbiol. 15: 1049-1053.
37. Loughman JA, Caparon MG. 2006. A novel adaptation of aldolase regulates virulence in Streptococcus pyogenes. EMBO J. 25:5414 -5422.
38. Hanski E, Horwitz PA, Caparon MG. 1992. Expression of protein F, the fibronectin-binding protein of Streptococcus pyogenes JRS4, in heterologous streptococcal and enterococcal strains promotes their adherence to respiratory epithelial cells. Infect. Immun. 60:5119 -5125.
39. Fogg GC, Gibson CM, Caparon MG. 1994. The identification of rofA, a positive-acting regulatory component of prtF expression: use of an m gamma delta-based shuttle mutagenesis strategy in Streptococcus pyogenes. Mol. Microbiol. 11:671- 684.
40. Caligioni CS. 2009. Assessing reproductive status/stages in mice. Curr. Protoc. Neurosci. Appendix 4:Appendix 4I. doi:10.1002/0471142301 .nsa04is48.
41. Lyon WR, Gibson CM, Caparon MG. 1998. A role for trigger factor and an rgg-like regulator in the transcription, secretion and processing of the cysteine proteinase of Streptococcus pyogenes. EMBO J. 17:6263- 6275.
42. Caparon MG, Stephens DS, Olsen A, Scott JR. 1991. Role of M protein in adherence of group A streptococci. Infect. Immun. 59:1811-1817.
43. Ferretti JJ, McShan WM, Ajdic D, Savic DJ, Savic G, Lyon K, Primeaux C, Sezate S, Suvorov AN, Kenton S, Lai HS, Lin SP, Qian Y, Jia HG, Najar FZ, Ren Q, Zhu H, Song L, White J, Yuan X, Clifton SW, Roe BA, McLaughlin R. 2001. Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc. Natl. Acad. Sci. U. S. A. 98:4658-4663.
44. Perez-Casal J, Price JA, Maguin E, Scott JR. 1993. An M protein with a single C repeat prevents phagocytosis of Streptococcus pyogenes: use of a temperature-sensitive shuttle vector to deliver homologous sequences to the chromosome of S. pyogenes. Mol. Microbiol. 8:809-819.
45. Ryan PL, Baum DL, Lenhart JA, Ohleth KM, Bagnell CA. 2001. Expression of uterine and cervical epithelial cadherin during relaxin-induced growth in pigs. Reproduction 122:929 -937.
46. Schmittgen TD, Livak KJ. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3:1101-1108.
47. Brenot A, King KY, Caparon MG. 2005. The PerR regulon in peroxide resistance and virulence of Streptococcus pyogenes. Mol. Microbiol. 55: 221-234.
48. Gibson CM, Mallett TC, Claiborne A, Caparon MG. 2000. Contribution of NADH oxidase to aerobic metabolism of Streptococcus pyogenes. J. Bacteriol. 182:448-455.
49. Sheen TR, Jimenez A, Wang NY, Banerjee A, van Sorge NM, Doran KS. 2011. Serine-rich repeat proteins and pili promote Streptococcus agalactiae colonization of the vaginal tract. J. Bacteriol. 193:6834-6842.
50. Scott JR, Guenthner PC, Malone LM, Fischetti VA. 1986. Conversion of an M-group A streptococcus toMby transfer of a plasmid containing an M6 gene. J. Exp. Med. 164:1641-1651.
51. Skinner JM, Caro-Aguilar IC, Payne AM, Indrawati L, Fontenot J, Heinrichs JH. 2011. Comparison of rhesus and cynomolgus macaques in a Streptococcus pyogenes infection model for vaccine evaluation. Microb. Pathog. 50:39-47.
52. Seidl K, Goerke C, Wolz C, Mack D, Berger-Bachi B, Bischoff M. 2008. Staphylococcus aureus CcpA affects biofilm formation. Infect. Immun. 76: 2044-2050.
53. Neely MN, Pfeifer JD, Caparon M. 2002. Streptococcus-zebrafish model of bacterial pathogenesis. Infect. Immun. 70:3904 -3914.
54. Medina E. 2010. Murine model of cutaneous infection with Streptococcus pyogenes. Methods Mol. Biol. 602:395- 403.
55. Packiam M, Veit SJ, Anderson DJ, Ingalls RR, Jerse AE. 2010. Mouse strain-dependent differences in susceptibility to Neisseria gonorrhoeae infection and induction of innate immune responses. Infect. Immun. 78: 433-440.
56. Straub RH. 2007. The complex role of estrogens in inflammation. Endocr. Rev. 28:521-574.
57. Cvoro A, Tatomer D, Tee MK, Zogovic T, Harris HA, Leitman DC. 2008. Selective estrogen receptor-beta agonists repress transcription of proinflammatory genes. J. Immunol. 180:630-636.
58. Seidl K, Stucki M, Ruegg M, Goerke C, Wolz C, Harris L, Berger-Bachi B, Bischoff M. 2006. Staphylococcus aureus CcpA affects virulence determinant production and antibiotic resistance. Antimicrob. Agents Chemother. 50:1183-1194.
59. Wen ZT, Burne RA. 2002. Functional genomics approach to identifying genes required for biofilm development by Streptococcus mutans. Appl. Environ. Microbiol. 68:1196 -1203.
60. Antunes A, Martin-Verstraete I, Dupuy B. 2011. CcpA-mediated repression of Clostridium difficile toxin gene expression. Mol. Microbiol. 79:882- 899.
61. Zheng L, Chen Z, Itzek A, Herzberg MC, Kreth J. 2012. CcpA regulates biofilm formation and competence in Streptococcus gordonii. Mol. Oral Microbiol. 27:83-94.
62. Iyer R, Baliga NS, Camilli A. 2005. Catabolite control protein A (CcpA) contributes to virulence and regulation of sugar metabolism in Streptococcus pneumoniae. J. Bacteriol. 187:8340-8349.
63. Rajan N, Cao Q, Anderson BE, Pruden DL, Sensibar J, Duncan JL, Schaeffer AJ. 1999. Roles of glycoproteins and oligosaccharides found in human vaginal fluid in bacterial adherence. Infect. Immun. 67:5027-5032.
64. Sumawong V, Gregoire AT, Johnson WD, Rakoff AE. 1962. Identification of carbohydrates in the vaginal fluid of normal females. Fertil. Steril. 13:270 -280.
65. Seki M, Iida K, Saito M, Nakayama H, Yoshida S. 2004. Hydrogen peroxide production in Streptococcus pyogenes: involvement of lactate oxidase and coupling with aerobic utilization of lactate. J. Bacteriol. 186: 2046-2051.
66. Saito M, Ohga S, Endoh M, Nakayama H, Mizunoe Y, Hara T, Yoshida S. 2001. H(2)O(2)-nonproducing Streptococcus pyogenes strains: survival in stationary phase and virulence in chronic granulomatous disease. Microbiology 147:2469 -2477.
67. Wagner G, Levin RJ, Bohr L. 1988. Diaphragm insertion increases human vaginal oxygen tension. Am. J. Obstet. Gynecol. 158:1040 -1043.
68. Al-Mushrif S, Jones BM. 1998. A study of the prevalence of hydrogen peroxide generating lactobacilli in bacterial vaginosis: the determination of H2O2 concentrations generated, in vitro, by isolated strains and the levels found in vaginal secretions of women with and without infection. J. Obstet. Gynaecol. 18:63- 67.
69. Wilks M, Wiggins R, Whiley A, Hennessy E, Warwick S, Porter H, Corfield A, Millar M. 2004. Identification and H(2)O(2) production of vaginal lactobacilli from pregnant women at high risk of preterm birth and relation with outcome. J. Clin. Microbiol. 42:713-717.
70. Klebanoff SJ, Hillier SL, Eschenbach DA, Waltersdorph AM. 1991. Control of the microbial flora of the vagina by H2O2-generating lactobacilli. J. Infect. Dis. 164:94 -100.
71. Wagner G, Bohr L, Wagner P, Petersen LN. 1984. Tampon-induced changes in vaginal oxygen and carbon dioxide tensions. Am. J. Obstet. Gynecol. 148:147-150.
72. Carvalho SM, Kloosterman TG, Kuipers OP, Neves AR. 2011. CcpA ensures optimal metabolic fitness of Streptococcus pneumoniae. PLoS One 6:e26707. doi:10.1371/journal.pone.0026707.
73. Pericone CD, Overweg K, Hermans PW, Weiser JN. 2000. Inhibitory and bactericidal effects of hydrogen peroxide production by Streptococcus pneumoniae on other inhabitants of the upper respiratory tract. Infect. Immun. 68:3990 -3997.
74. Regev-Yochay G, Trzcinski K, Thompson CM, Lipsitch M, Malley R. 2007. SpxB is a suicide gene of Streptococcus pneumoniae and confers a selective advantage in an in vivo competitive colonization model. J. Bacteriol. 189:6532- 6539.
75. Spellerberg B, Cundell DR, Sandros J, Pearce BJ, Idanpaan-Heikkila I, Rosenow C, Masure HR. 1996. Pyruvate oxidase, as a determinant of virulence in Streptococcus pneumoniae. Mol. Microbiol. 19:803- 813.
76. Orihuela CJ, Gao G, Francis KP, Yu J, Tuomanen EI. 2004. Tissuespecific contributions of pneumococcal virulence factors to pathogenesis. J. Infect. Dis. 190:1661-1669.
77. Ramos-Montanez S, Tsui HC, Wayne KJ, Morris JL, Peters LE, Zhang F, Kazmierczak KM, Sham LT, Winkler ME. 2008. Polymorphism and regulation of the spxB (pyruvate oxidase) virulence factor gene by a CBSHotDog domain protein (SpxR) in serotype 2 Streptococcus pneumoniae. Mol. Microbiol. 67:729 -746.